Oak Hill Advisors LP

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Oak Hill Advisors LP reported 12 stock positions worth $572.2 million. Its top holding was Valaris (VAL) at 46.7% of the portfolio, followed by Expro (XPRO, 36.4%) and Sabre (SABR, 6.5%). Compared with Q2 2024, it opened 1 new position. The biggest buy was a new position in Emergent Biosolutions (EBS).

Most Recent 13F
Q2 2026
Location
New York, NY
CIK
0001164688
Portfolio Value
$572.2M (Q3 2024)
SEC Filing
0001172661-24-004755 ↗ filed Nov 14, 2024

Holdings Value

0$200.0M$400.0M$600.0M$800.0M$1.0B Q1 2024: $750.0M Q1 2024 Q2 2024: $708.1M Q2 2024 Q3 2024: $572.2M $572.2M Q3 2024 Q4 2024: $461.1M Q4 2024 Q1 2025: $390.3M Q1 2025 Q2 2025: $396.9M Q2 2025 Q3 2025: $465.4M Q3 2025 Q4 2025: $598.4M Q4 2025 Q1 2026: $877.9M Q1 2026 Q2 2026: $700.9M Q2 2026

Holdings 12 stocks · $572.2M

VAL Valaris Ltd. 46.66% 4,788,982 $267.0M No change
XPRO Expro Group Holdings NV 36.41% 12,133,007 $208.3M No change
SABR Sabre Corp. 6.53% 10,177,079 $37.3M No change
XJQCX Nuveen Credit Strategies Inc. 3.36% 3,325,126 $19.3M No change
EBS Emergent Biosolutions Inc. 1.62% 1,113,338 $9.3M New
HYT BlackRock Corp. Hi YLD 1.59% 906,116 $9.1M No change
IHRT Iheartmedia Inc. Class A 1.58% 4,880,530 $9.0M No change
DSU BlackRock Debt Strategies 1.15% 597,004 $6.6M No change
XEVVX Eaton Vance Ltd. Durat Inc. 0.74% 403,604 $4.2M No change
CMLSQ Cumulus Media Inc. Class A 0.12% 531,813 $697K No change
BRW Saba Capital Income & Opport 0.12% 90,832 $689K No change
CTEV Claritev Corp. filed as MULTIPLAN CORPORATION 0.12% 87,463 $668K No change
Other holdings (2): bonds, preferreds, convertibles and warrants · $96.2M (not counted above)
SecurityClassShares / PrincipalValueChange
SABRE GLBL INC (SABHLD 4 04/15/25) NOTE 4.000% 4/1 · principal 95,148,000$94.2MNo change
CABLE ONE INC (CABO 0 03/15/26) NOTE 3/1 · principal 2,100,000$1.9MNo change

Total filed on the 13F, all lines: $668.4M.

Portfolio Sells Q2 2024 → Q3 2024

None this quarter.

Portfolio Buys Q2 2024 → Q3 2024

EBS Emergent Biosolutions Inc. New 1.62% +1.62

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 12$700.9MVAL, XPRO, FSK, FSSL, IHRT
Q1 2026 12$877.9MVAL, XPRO, FSK, FSSL, XJQCX
Q4 2025 12$598.4MVAL, XPRO, EBS, FSSL, FSK
Q3 2025 11$465.4MVAL, XPRO, SABR, XJQCX, EBS
Q2 2025 11$396.9MVAL, XPRO, SABR, XJQCX, EBS
Q1 2025 12$390.3MVAL, XPRO, SABR, XJQCX, HYT
Q4 2024 12$461.1MVAL, XPRO, SABR, XJQCX, EBS
Q3 2024Amended 12$572.2MVAL, XPRO, SABR, XJQCX, EBS
Q2 2024Amended 11$708.1MVAL, XPRO, SABR, XJQCX, HYT
Q1 2024 12$750.0MVAL, XPRO, SABR, XJQCX, VVR